<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11862121</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.557</article-id><article-id pub-id-type="other">EPP0397</article-id><article-id pub-id-type="pii">S0924933824005571</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Divergent risk of SARS-CoV-2 infection, severe COVID-19 and mortality across psychiatric disorders: analysis from electronic health records in Catalonia</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Monistrol-Mula</surname><given-names>A.</given-names></name><xref rid="aff1257" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor0418" ref-type="corresp">
<sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>F&#x000e9;lez-Nobrega</surname><given-names>M.</given-names></name><xref rid="aff1257" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gin&#x000e9;-V&#x000e1;zquez</surname><given-names>I.</given-names></name><xref rid="aff1257" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Haro</surname><given-names>J. M.</given-names></name><xref rid="aff1257" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff1257">
<sup>1</sup>Epidemiology of mental disorders and ageing, <institution>Institut de Recerca Sant Joan de Deu</institution>, <city>Sant Boi de Llobregat</city>, <country>Spain</country>
</aff><author-notes><corresp id="cor0418">
<label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="532">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S264</fpage><lpage>S265</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824005571a.pdf"/><abstract><sec id="sec2509"><title>Introduction</title><p>People with psychiatric disorders are particularly vulnerable to SARS-CoV-2 infection and its associated complications. However, current literature show that not all psychiatric disorders are equally vulnerable to COVID-19.</p></sec><sec id="sec2510"><title>Objectives</title><p>This study aimed to assess whether individuals with distinct psychiatric disorders exhibit different risk of SARS-CoV-2 infection, COVID-19 hospitalization, and mortality.</p></sec><sec id="sec2511"><title>Methods</title><p>We conducted a case-control study using data of electronic health records from Catalonia. Cases included adults with a hospital admission between 2017 and 2019 for non-affective psychosis, bipolar disorder, depressive disorder, stress-related disorders, neurotic/somatoform disorders, and substance misuse. These were matched to patients without a diagnosis by sex, 5-year age band, and living area. Outcomes included SARS-CoV-2 infection, hospitalization, and COVID-19-related death up to December 2021. Logistic regression analysis were employed to test the association between the six groups of psychiatric disorders and COVID-19 outcomes, controlling for age, sex, smoking, being in a nursing home, and physical comorbidities.</p></sec><sec id="sec2512"><title>Results</title><p>785,378 subjects were included. Preliminary findings showed that patients diagnosed with psychosis and bipolar disorder had lower risk of infection [OR: 0.85 (95% CI: 0.79-0.92), <italic toggle="yes">p</italic>&#x0003c;0.001; OR: 0.84 (95% CI: 0.76-0.92), <italic toggle="yes">p</italic>&#x0003c;0.001], whereas individuals with stress-related and neurotic/somatoform disorders had higher risk of infection [OR: 1.08 (95% CI: 1.04-1.14), <italic toggle="yes">p</italic>&#x0003c;0.001; OR: 1.06 (95% CI: 1.03-1.10), <italic toggle="yes">p</italic>&#x0003c;0.001]. People with depressive, stress-related, and neurotic/somatoform disorders had lower risk of COVID-19 hospitalization [OR: 0.87 (95% CI: 0.78-0.97), <italic toggle="yes">p</italic> = 0.01; OR: 0.71 (95% CI: 0.61-0.84), <italic toggle="yes">p</italic>&#x0003c;0.001; OR: 0.67 (95% CI: 0.60-0.76), <italic toggle="yes">p</italic>&#x0003c;0.001]. In line with these results, individuals with stress-related disorders also experienced lower mortality [0.49 (95% CI: 0.33-0.70), <italic toggle="yes">p</italic>&#x0003c;0.001]. Conversely, people with psychosis, bipolar disorder, and substance misuse exhibited higher risk of COVID-19-related death [OR: 2.9 (95% CI: 1.68-3.1), <italic toggle="yes">p</italic>&#x0003c;0.001; OR: 1.95 (95% CI: 1.30-2.81), <italic toggle="yes">p</italic>&#x0003c;0.001; OR: 1.82 (95% CI: 1.49-2.20), <italic toggle="yes">p</italic>&#x0003c;0.001].</p></sec><sec id="sec2513"><title>Conclusions</title><p>We found different risks of SARS-CoV-2 infection, COVID-19 hospitalization, and COVID-19 mortality for psychiatric disorder groups. Differences in vulnerability to COVID-19 among people with psychiatric disorders might be explained by factors such as shared living facilities, physical comorbidities, psychotropic medications, and difficulties in accessing high-intensity medical care. Special attention should be directed towards individuals with psychosis, bipolar disorder, and substance misuse.</p></sec><sec id="sec2514"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front></article>